TotalEnergies, Aramco To Invest $11 Bln To Construct Petrochemical Facility In Saudi Arabia

TotalEnergies SE (TTE), a French energy and petroleum company, and The Saudi Arabian Oil Company or Saudi Aramco have decided to invest towards constructing a large scale petrochemical facility- Amiral in Saudi Arabia.

The project involves an investment of around $11 billion, of which $4 billion will be funded through 62.5 percent equity by Aramco, and the remaining 37.5 percent by TotalEnergies.

In future, the complex will provide feedstock to other petrochemical and chemical plants, located in the Jubail industrial area, which will be built by downstream investors, entailing an estimated additional $4 billion of investments.

The complex will be owned, operated, and integrated with the existing SATORP refinery located in Jubail.

The petrochemical facility will enable SATORP to convert internally produced refinery off-gases and naphtha, as well as ethane and natural gasoline supplied by Aramco, into higher value chemicals.

Amiral will have a mixed feed cracker capable of producing 1.65 million tons per annum of ethylene.

The construction of the project is scheduled to begin during the first quarter of 2023, with commercial operation expected in 2027.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
United Airlines and Archer Aviation Inc. announced plans to launch the first commercial electric air taxi route in Chicago, between O'Hare International Airport or ORD and Vertiport Chicago. As part of their urban air mobility or UAM network buildout, both companies will utilize Archer's electric vertical takeoff and landing or eVTOL aircraft in the new route. Fort Wayne, Indiana-based Perfection Bakeries D/B/A Aunt Millie's is recalling 8 ct. packages of Our Family White Hot Dog Buns citing the possible presence of undeclared sesame, a known allergen, the U.S. Food and Drug Administration said. The product comes in a printed plastic package marked with "Our Family Hot Dog Buns 8 ct." on the top and has a blue twist tie. Parsippany, New Jersey -based Ascend Laboratories LLC. is recalling Dabigatran Etcxilate capsules citing the detection of N-Nitrosodimethylamine or NDMA impurity, a probable human carcinogen, the U.S. Food and Drug Administration said. The product is used as an oral anticoagulant to lower the risk of stroke and blood clots.
Follow RTT